文献速递肝病

肝硬化中的固有免疫细胞

Innate immune cells in cirrhosis.
PubMed 文献 · J Hepatol · 2020-03-30

本文综述肝硬化中固有免疫细胞的持续与独特扰动。肝硬化患者易感细菌感染,可诱发急性失代偿和慢加急性肝衰竭,短期死亡率高。肝巨噬细胞(Kupffer细胞)与驻留肥大细胞活化产生促炎和血管通透性介质,招募中性粒细胞、淋巴细胞、嗜酸性粒细胞和单核细胞至肝脏并促进组织损伤。随着肝硬化进展,损伤相关和病原相关分子模式激活免疫细胞,促进系统性炎症反应;循环中性粒细胞和单核细胞的抗菌功能逐渐严重受损,机制复杂且尚未完全阐明。本文还综述了潜在治疗靶点。

要点

  • 肝硬化患者固有免疫细胞持续扰动,易感细菌感染并诱发急性失代偿和慢加急性肝衰竭。
  • 肝巨噬细胞和肥大细胞活化释放促炎与血管通透介质,招募免疫细胞并促进肝损伤。
  • 循环中性粒细胞和单核细胞抗菌功能随肝硬化加重逐渐严重受损。

核心结论

  • 肝硬化中固有免疫细胞发生持续且独特的扰动,影响疾病进展,并存在潜在治疗靶点。

研究设计与样本

  • 本文为综述,聚焦肝硬化中固有免疫细胞的持续与独特扰动及其对疾病进展的影响。

主要发现

  • 肝硬化患者易感细菌感染,感染可诱发急性失代偿和慢加急性肝衰竭,两者均与高短期死亡率相关。
  • 肝巨噬细胞(Kupffer细胞)和驻留肥大细胞活化产生促炎和血管通透性介质,诱导中性粒细胞、淋巴细胞、嗜酸性粒细胞和单核细胞在肝脏积聚并促进组织损伤。
  • 肝硬化进展中,损伤相关和病原相关分子模式激活免疫细胞,促进可累及不同组织和腔室的系统性炎症反应。
  • 随着肝硬化恶化,循环中性粒细胞和单核细胞的抗菌功能逐渐且严重受损,促进疾病进展。
  • 抗菌反应受损的机制复杂且尚未完全理解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cirrhosis is a multisystemic disease wherein inflammatory responses originating from advanced liver disease and its sequelae affect distant compartments. Patients with cirrhosis are susceptible to bacterial infections, which may precipitate acute decompensation and acute-on-chronic liver failure, both of which are associated with high short-term mortality. Innate immune cells are an essential first line of defence against pathogens. Activation of liver macrophages (Kupffer cells) and resident mastocytes generate proinflammatory and vaso-permeating mediators that induce accumulation of neutrophils, lymphocytes, eosinophils and monocytes in the liver, and promote tissue damage. During cirrhosis progression, damage- and pathogen-associated molecular patterns activate immune cells and promote development of systemic inflammatory responses which may involve different tissues and compartments. The antibacterial function of circulating neutrophils and monocytes is gradually and severely impaired as cirrhosis worsens, contributing to disease progression. The mechanisms underlying impaired antimicrobial responses are complex and incompletely understood. This review focuses on the continuous and distinct perturbations arising in innate immune cells during cirrhosis, including their impact on disease progression, as well as reviewing potential therapeutic targets.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Bernsmeier C, van der Merwe S, Périanin A, et al. Innate immune cells in cirrhosis. J Hepatol. 2020. PMID: 32240716. doi:10.1016/j.jhep.2020.03.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。